drugset / Trial / NCT01523275

Study of Mitomycin-C Application in Laryngotracheal Stenosis

NCT01523275

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, prospective, double-blind, placebo-controlled clinical trial of the use of mitomycin-C topical application as an adjunctive treatment in the endoscopic surgical treatment of patients with laryngotracheal stenosis. We hypothesize that the use of mitomycin-C improves patient outcome in the endoscopic surgical treatment of laryngotracheal stenosis.

Timeline

Start
2012-08
Primary completion
2018-02
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Mitomycin C Other / unclassified 0.4 mg/ml Topical